Skip to main content
OpenTrials
Completed

NCT Number: NCT02790346

Talonavicular Arthrodesis and Surgical Treatment of Ankle and Varus Foot

This study should refine our surgical indications and to establish a decision tree of medical and surgical treatment of this common and troublesome strain functionally which is equino-varus.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHRU Lapeyronie

Montpellier, Herault, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hemiparesis secondary to a lesion of the central nervous system, regardless of the etiology dated within 6 months
  • Orthopedic equine-varus deformity of the foot and ankle requiring surgery
  • Patient able to move by walking preoperatively at least 2 meters with or without technical assistance or may earn postoperative walking ability

Exclusion criteria

  • History of foot surgery the side to be operated
  • Significant deformation set foot and ankle (requiring treatment with triple arthrodesis)
  • Bilateral surgery
  • Progressive neurological disease
  • Dystonic movements or movement disorders
  • Realization of a botulinum toxin injection in the 6 months preceding gesture
  • Important cognitive impairment

Treatment and study plan

arthrodesis talonavicular

Procedure

tendon gestures

Procedure

Primary outcomes

  1. walking speed at one year

    Time frame: 12 months after surgery intervention

Secondary outcomes

  1. walking speed at 3 and 6 months

    Time frame: 3 months and 6 months after surgery intervention

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Interest of Talonavicular Arthrodesis on Walking Speed at Brain Lesion Patients Who Benefit of a Surgical Treatment of Ankle and Varus Foot : Randomized Study

Acronym: talobot

Important dates

Study start
2015
Primary completion
2023
Study completion
2023
First posted
Jun 3, 2016
Registry last updated
Mar 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.